Debasish Banerjee (@debukidney) 's Twitter Profile
Debasish Banerjee

@debukidney

Professor and consultant in Renal Medicine #KidneyDoctor Passionate about cardiovascular complications of CKD and #kidneyeducation

ID: 1157989343673368576

linkhttps://www.stgeorges.nhs.uk/people/dr-debasish-banerjee/ calendar_today04-08-2019 12:19:08

326 Tweet

367 Followers

22 Following

NEJM (@nejm) 's Twitter Profile Photo

ALIGN: In a prespecified interim analysis of a phase 3, randomized, controlled trial, the selective endothelin type A receptor inhibitor atrasentan reduced proteinuria in patients with IgA nephropathy, without apparent safety issues. nej.md/3NzvISW #KidneyWk

ALIGN: In a prespecified interim analysis of a phase 3, randomized, controlled trial, the selective endothelin type A receptor inhibitor atrasentan reduced proteinuria in patients with IgA nephropathy, without apparent safety issues. nej.md/3NzvISW #KidneyWk
NEJM (@nejm) 's Twitter Profile Photo

Among participants with obesity and pain related to knee osteoarthritis, treatment with weekly semaglutide for 68 weeks resulted in greater reductions in body weight and knee pain than placebo. Full STEP 9 trial results: nej.md/40oSLHB

Among participants with obesity and pain related to knee osteoarthritis, treatment with weekly semaglutide for 68 weeks resulted in greater reductions in body weight and knee pain than placebo. Full STEP 9 trial results: nej.md/40oSLHB
NEJM (@nejm) 's Twitter Profile Photo

The U.S. falls short when it comes to both protecting the health of individual people and promoting societal well-being, write David Blumenthal, Evan Gumas, and Arnav Shah, in a new Perspective. Learn more: nej.md/3BCsonk

The U.S. falls short when it comes to both protecting the health of individual people and promoting societal well-being, write <a href="/DavidBlumenthal/">David Blumenthal</a>, <a href="/GumasEvan/">Evan Gumas</a>, and Arnav Shah, in a new Perspective. Learn more: nej.md/3BCsonk
KDIGO (@gokdigo) 's Twitter Profile Photo

The KDIGO 2025 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD) is available for public review through Friday, November 22. You can download the public review draft and share comments via the feedback survey on the KDIGO Anemia in CKD Guideline Website:

The KDIGO 2025 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD) is available for public review through Friday, November 22. 

You can download the public review draft and share comments via the feedback survey on the KDIGO Anemia in CKD Guideline Website:
Debasish Banerjee (@debukidney) 's Twitter Profile Photo

Another treatment for HFpEF Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | New England Journal of Medicine nejm.org/doi/full/10.10…

Debasish Banerjee (@debukidney) 's Twitter Profile Photo

Stanniocalcin-1: A Novel Mediator in Diabetic Kidney Disease and Cardiovascular Disease - Kidney International Reports kireports.org/article/S2468-…

Debasish Banerjee (@debukidney) 's Twitter Profile Photo

Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials - The Lancet Diabetes & Endocrinology thelancet.com/journals/landi…

KIReports (@kireports) 's Twitter Profile Photo

SGLT2 Inhibitor #SGLT2i in #Diabetic and #NonDiabetic Renal #Transplant Recipients #VisualAbstract by Dr P S Vali kireports.org/article/S2468-…

SGLT2 Inhibitor  #SGLT2i in #Diabetic and #NonDiabetic Renal #Transplant Recipients

#VisualAbstract by <a href="/DrPSVali/">Dr P S Vali</a>

kireports.org/article/S2468-…
Debasish Banerjee (@debukidney) 's Twitter Profile Photo

Wandsworth Council gives green light on plans to build one of the UK’s largest kidney units - St George's University Hospitals NHS Foundation Trust stgeorges.nhs.uk/newsitem/wands… via @StGeorgesTrust St George's, Epsom and St Helier Anna

Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) 's Twitter Profile Photo

Co-Chaired a session with Debasish Banerjee on Renal Resilience - Recent Advances in Clinical Knowledge and Future Treatment of Rare Orphan Diseases with the likes of Katalin Susztak Ariela Benigni Claire & Yaacov Frishberg, at the World Congress of Nephrology in New Delhi #ISNWCN

Co-Chaired a session with <a href="/debukidney/">Debasish Banerjee</a> on Renal Resilience - Recent Advances in Clinical Knowledge and Future Treatment of Rare Orphan Diseases with the likes of <a href="/KSusztak/">Katalin Susztak</a> <a href="/ariela_benigni/">Ariela Benigni</a> <a href="/ClaireSharpe22/">Claire</a> &amp; Yaacov Frishberg, at the World Congress of Nephrology in New Delhi #ISNWCN
Vandana Dua Niyyar (@vandyniyyar) 's Twitter Profile Photo

Thank you very much for the invitation Prabir Roy Chaudhury - honored to be included with such august company! A truly memorable evening-enjoyed the fun conversations & the futuristic perspectives of leaders in nephrology! And being in Delhi was the icing on the cake🥰World Congress of Nephrology #ISNWCN

Prabir Roy Chaudhury (@proychaudhurymd) 's Twitter Profile Photo

Honored to present on disruptive change in Vascular Access at the Vascular Access Society meeting in Padua, Italy. Wonderful to meet old friends ⁦UNC Department of Medicine

Honored to present on disruptive change in Vascular Access at the Vascular Access Society meeting in Padua, Italy.
Wonderful to meet old friends
⁦<a href="/UNCDeptMedicine/">UNC Department of Medicine</a>⁩
Int Society of Nephrology (@isnkidneycare) 's Twitter Profile Photo

8️⃣.2️⃣ Optimization of SGLT2i Therapy Toolkit: The second in a joint cardio-nephrology series, featuring educational and clinical infographics to support SGLT2i therapy use: lite.spr.ly/6006Hy44

8️⃣.2️⃣ Optimization of SGLT2i Therapy Toolkit: The second in a joint cardio-nephrology series, featuring educational and clinical infographics to support SGLT2i therapy use: lite.spr.ly/6006Hy44